Can Valacyclovir Attenuate Inflammation in Antiretroviral-Treated HIV-Infected Individuals With Herpes Simplex Virus Type 2?

NCT01176409 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Human Immunodeficiency Virus
Herpes Simplex

Interventions

DRUG: Valacyclovir
DRUG: Placebo

Sponsor

University Health Network, Toronto

Collaborators

[object Object]
[object Object]